NBIX - Neurocrine Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NBIX is currently covered by 24 analysts with an average price target of $168.05. This is a potential upside of $27.15 (19.27%) from yesterday's end of day stock price of $140.9.

Neurocrine Biosciences's activity chart (see below) currently has 345 price targets and 320 ratings on display. The stock rating distribution of NBIX is 77.14% BUY and 22.86% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.2% with an average time for these price targets to be met of 269.94 days.

Highest price target for NBIX is $184, Lowest price target is $115, average price target is $164.29.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 05-Sep-2025. First documented stock forecast 04-Feb-2015.

Currently out of the existing stock ratings of NBIX, 81 are a BUY (77.14%), 24 are a HOLD (22.86%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$163

$21.13 (14.89%)

$158

11 days ago
(05-Sep-2025)

7/14 (50%)

$18.9 (13.12%)

453

Buy

$149

$7.13 (5.03%)

$144

11 days ago
(05-Sep-2025)

19/23 (82.61%)

$4.9 (3.40%)

113

Buy

$174

$32.13 (22.65%)

$144

1 months 16 days ago
(31-Jul-2025)

19/20 (95%)

$45.77 (35.69%)

504

Buy

$141

$-0.87 (-0.61%)

$147

1 months 16 days ago
(31-Jul-2025)

12/13 (92.31%)

$12.77 (9.96%)

439

Buy

$175

$33.13 (23.35%)

$154

1 months 16 days ago
(31-Jul-2025)

13/17 (76.47%)

$46.77 (36.47%)

375

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NBIX (Neurocrine Biosciences) average time for price targets to be met?

On average it took 269.94 days on average for the stock forecasts to be realized with a an average price target met ratio 80.2

Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?

Danielle Brill works at RAYMOND JAMES and has 7 price targets and 7 ratings on NBIX

Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?

Jay Olson with highest potential upside - $77.13

Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?

Thomas Wei with lowest potential downside - -$69.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?